BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
The most kind people I've ever worked with.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Really great environment where you can feel comfortable working
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
They are kind, respective and fully devoted into their vision
Qu’est-ce qui vous rend le plus heureux au travail?
The ability to do what I can to support the activities of the company
Other Employee Reviews for BlueRock Therapeutics
×